Live Markets
Wednesday, July 29, 2026·George Town, KY·29°·Partly Cloudy
Markets Open · NYSE·Newsletter·Masthead·
VOL. XII · NO. 117Established MMXIV · George Town, Grand CaymanAtlantic Edition · $4.50

The Cayman Journal

Finance · Business · Technology · Caribbean & Global Affairs
Markets · Healthcare

Mangoceuticals, Inc. (MGRX)

NCM · Health Information Services

$0.56+0.01 (+2.39%)Quote refreshed

Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires

Market Cap
$9.5M
P/E (TTM)
EPS
$-1.31
Div Yield
52W Range
$0.16–$2.75
Beta
2.28

Company overview

Mangoceuticals, Inc. engages in the development, marketing, and sale of various men's wellness products and services through a telemedicine platform in the United States. The company offers erectile dysfunction products under the Mango brand; hair loss products under the Grow brand; hormone balance and therapy products under the Mojo brand; and weight loss products under the Slim brand. It also provides oral testosterone undecanoate to treat low testosterone in men and as a form of testosterone replacement therapy under the Prime brand; and access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations. In addition, the company markets and sells its products online through its website www.MangoRX.com. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.

Peers in Health Information Services

All in industry →

Recent press releases

Mangoceuticals, Inc. has not issued a press release in this window.

SEC filings

All filings →

Mangoceuticals, Inc. has not filed an SEC document in this window.

Mangoceuticals, Inc. has no reported insider trades in the last 90 days.

Institutional holders

All holders →
As of 2025-12-31 · prior 2025-09-30
1,536,000 sh● NEW
108,322 sh+23.1%
138,146 sh● NEW
489,532 sh+154.9%
34,500 sh0.0%
47,503 sh● NEW
46,167 sh+1538800.0%
38,441 sh● NEW

People at Mangoceuticals, Inc.

All people →

Quarterly financials

Full financials →
Revenue trend
03/25
$109.3K
NI -$4.8M
06/25
$168.1K
NI -$5.4M
09/25
$84.2K
NI -$7.6M
RevenueNI = Net Income
EPS trend (diluted)
Latest: $-0.69
Prior: $-0.57
Revenue sparkline